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Abstract Imp13, a member of importin-β superfamily, is
found to be one of two bidirectional transport receptors in
many nuclear transport activities in mammals. Several cargoes
of imp13 have been identified; most of these are essential
factors involved in cell cycle and development. The expres-
sion and localization of imp13 may influence its cargoes in
playing their roles in appropriate time and space. To gain
insight into the role of imp13 in brain development, we
generated an anti-imp13 polyclonal antibody and investigated
the expressions of imp13 in mouse embryonic brains during
development, including E13.5, E15.5, E17.5, P0, and adult, at
both transcriptional and translational levels. In addition, we
performed immunohistochemical analysis and revealed that
imp13 tends to be localized in the cytoplasm at the early stages
and relocates into the nucleus at the late stages in neuronal
cells of mouse brains. These findings suggested that the ex-
pression and localization of imp13 in brain tissues are regu-
lated developmentally, which extends our knowledge of the
dynamic presence of imp13. These observations also imply
that imp13 contributes to the neural cell-specific cargo traf-
ficking and potentially to other functions during brain
development.
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Introduction
Regulation of nuclear protein transportation through nuclear
pore complexes (NPCs) is an essential function in eukaryotic
cells. Most macromolecules larger than 40–60 kDa are
transported actively through the NPC mediated by transport
factors such as members of importin-β superfamily (Fabre
and Hurt 1994; Davis 1995; Macara 2001; Weis 2002).
Importin13 (imp13, lgl2, Kap13, or IPO13), a member of
the importin-β superfamily, is a nucleus–cytoplasm bidirec-
tional transporter that plays roles in cell differentiation, em-
bryonic development, and physiologic functions of several
organs, including lung, brain, and heart (Zhang et al. 2000;
Su et al. 2002; Tao et al. 2004; Tao et al. 2006; Lin et al. 2009).
Imp13 has been documented to be involved in nuclear import
or export of several nuclear proteins which include eIF1A,
Mago-Y14 and Ubc9 (Mingot et al. 2001), Pax6 (Ploski et al.
2004), NF-YB/NF-YC dimer (Kahle et al. 2005), the
gulcocorticoid receptor (GR) (Tao et al. 2006), myopodin
(Liang et al. 2008), and Arx (Shoubridge et al. 2007; Lin et
al. 2009). Some of these substrates are important in embryonic
neural development. For example, PAX6 is a master control
gene for eye morphogenesis (Gehring 1996) and ARX is
necessary for the development of forebrain (Lin et al. 2009).
Imp13 affects neurotransmitter release at the Drosophila neu-
romuscular junction (Giagtzoglou et al. 2009). Imp13 is ex-
clusively expressed in the basal cells of human limbal
epithelia and regulates differentiation and proliferation of
corneal epithelial progenitor cells (Wang et al. 2009). These
findings imply that imp13 may play essential roles in neural
development.
Expression and localization of nucleocytoplasmic trans-
porters have drawn a lot of interest recently. Importin pro-
teins show regulated expression patterns in cells and tissues
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at both RNA and protein levels, indicating that nuclear
import of the cargo proteins depends on the presence of
different amounts of importins (Jans et al. 2000; Itman et
al. 2009; Yasuhara et al. 2009). Because of the intrinsic
selectivity importin proteins display for different cargoes,
their differential expression patterns during development
and differentiation are suggested to be a potential regulatory
mechanism (Yamaguchi et al. 2006; Terry et al. 2007;
Okada et al. 2008; Yasuhara et al. 2009; Whiley et al.
2012; Yasuda et al. 2012). Several lines of evidence show
regulated importin expression during embryonic develop-
ment (Kamei et al. 1999; Hogarth et al. 2006; Loveland et
al. 2006; Hogarth et al. 2007; Nakamura et al. 2007; Quan et
al. 2008). However, neither expression nor subcellular lo-
calization of imp13 in brain development has been closely
examined. In this study, we generated a rabbit anti-imp13
antibody to analyze both expression and localization of
endogenous imp13 in embryonic mouse brain tissues. Our
results revealed that both expression and subcellular locali-
zation of endogenous imp13 are dynamically changed in
some tissues of embryonic mouse brains, suggesting a sig-
nificance of spatial–temporal regulation of imp13 in mouse
brain development.
Materials and Methods
Preparation of a rabbit anti-imp13 antibody. To express
GST-tagged imp13 protein, cells of Escherichia coli BL21
carrying pGEX-4T-2-imp13 (Tao et al. 2004) were grown
overnight on LB-Amp plates and were used to inoculate 1 L of
prewarmed LB containing 100 μg/mL ampicillin. The cell
cultures were incubated at 37°C with vigorous shaking. At
an optical density of 0.7 at 600 nm, the cultures were rapidly
chilled to 20°C and 0.1 mM IPTG was added. Cells were
incubated for another 6 h and cells were harvested by centri-
fugation. Cells were lysed and GST-tagged imp13 proteins
were purified using Glutathione Sepharose 4B beads.
For antibody production, New Zealand white rabbits
were immunized subcutaneously using 0.5 mg GST-tagged
imp13 proteins per kilogram body weight after emulsified to
Freund’s complete adjuvant. Two weeks after primary in-
jection, booster injections were made using 0.5 mg fusion
protein per kilogram body weight with Freund’s incomplete
adjuvant. Twelve days after monthly booster injections, anti-
sera were collected from an artery in the ear. Finally, the
purified rabbit anti-imp13 antibody was prepared after ab-
sorbing GST antibody with GST beads.
Animals and tissues. All animal experimental procedures
were conducted in accordance with the guide for the care
and use of laboratory animals, provided by the Xiamen
University Laboratory Animal Center, Xiamen, China.
C57/BL-6 mouse embryos at different developmental stages
were collected (three mice per group) for real-time RT–PCR,
Western blot, and immunohistochemical analysis. Brains of
E11.5, E13.5, E15.5, and E17.5 were carefully dissected out
from the skulls and placed into ice-cold phosphate-buffered
saline (PBS); for P0 and adult mice, after a deep anesthesia,
the animals were perfused with cold 4% paraformaldehyde
transcardially using a peristaltic perfusion connected with an
18-gauge needle through the left ventricle and by clamping
the descending aorta. Then, after perfusion, the animals were
decapitated, the skulls were taken off, and the brains were
carefully removed. For immunostaining, all samples were
dehydrated and embedded in paraffin and cut into 4-μm-
thick sections with a diamond knife with an ultra-microtome
(Leica RM2255, Nussloch, Germany).
Analysis of real-time RT–PCR. Total RNAs were isolated
with RNAfast 1000 (Feijie, China) and all primers and
probes were ordered from Applied Biosystems (Foster,
CA, USA). The sequence of the primers and probes used for
TaqMan RT–PCR amplification are as follows: a forward
primer (5′-ACAGCCCCAAAATGGTTAAGGTT-3′), a re-
verse primer (5′-CCAACACTT CGAGAGGTCCTT-3′), and
the TaqMan MGB probe (FAM 5′-CCAACACTTCGAG
AGGTCCTT-3′ NFQ) were used for amplifying a 61-bp
fragment of the Hprt1 cDNA as internal control. A forward
primer (5′-GGCTCCAAAATTGTGCTGACT-3′), a reverse
primer (5′-GCATCATGCTGAGAG CTAGTGA-3′), and a
TaqMan MGB probe (FAM 5′-CCAGCGCCACGCACAG-
3′ NFQ) were used to amplify a 64-bp fragment of IPO13
cDNA. Analysis of real-time RT–PCR was carried out in a
total volume of 20 μL. The thermal cycle conditions were as
follows: 1×2 min 50°C, 1×10 min 95°C, followed by 40
cycles of reaction at 95°C for 15 s and combined
annealing/extension step at 60°C for 1 min. Expression of
IPO13 was normalized to HPRT using the 2−△△Ct method as
described (Tichopad et al. 2003; Kane et al. 2005).
Western blot analysis. Tissues were pulverized with a mor-
tar and pestle on ice and homogenized in the lysis buffer
(50 mM HEPES–NaOH, pH 7.5, 100 mM NaCl, 0.5% NP-
40, 2.5 mM EDTA, 10% glycerol, 1 mM DTT, 1 mM PMSF,
and 1% proteinase inhibitor cocktail). The homogenates
were centrifuged for 20 min at 12,000×g at 4°C. Protein
concentrations in the supernatants were measured with a
spectrophotometer (Bio-Rad SmartSpec 3000, El Cajon,
CA, USA). Protein extracts (60 μg per sample) were dena-
tured by boiling in 2× loading buffer (0.25 M Tris–HCl,
20% glycerol, 4% SDS, 0.005% bromoethanol blue, and 5%
β-mercaptoethanol) for 5 min, separated by 10% SDS–
PAGE, and transferred to a PVDF membrane. The mem-
brane was placed in blocking solution (5% non-fat dry milk
in TBST) for 1 h at room temperature and then incubated
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overnight at 4°C with either the rabbit anti-imp13 polyclonal
antibody at 1:1,000 dilution or a mouse anti-tubulin monoclonal
antibody at 1:1,000 dilution (#MAB5564, Chemicon,
Temecula, CA, USA). The membrane was rinsed three times,
for a total of 30 min in TBST, followed by incubation with
horseradish peroxidase-conjugated anti-rabbit or anti-mouse
IgG antibodies. The membrane was rinsed three times again
for 30 min total in TBSTand developed with ECL plusWestern
Blotting Detection Reagents (GE Healthcare, Piscataway, New
Jersey, USA).
Immunostaining. Immunohistochemical analysis was
performed using the rabbit anti-imp13 polyclonal antibody, a
rabbit anti-imp9 polyclonal antibody (#ab52605; Abcam, UK),
and a rabbit anti-impβ1 polyclonal antibody (#ab2811;
Abcam). Four-micrometer-thick serial sections were mounted
on glass slides coated by 3-aminopropyltriethoxysilane, and the
slides were dried overnight at 37°C followed by incubating for
30 min at 64°C. The sections were deparaffinized
in two changes of xylene and rehydrated in a series of descend-
ing concentrations of ethanol. Antigen retrieval was performed
by microwave heating the slides in 10 mM citrate buffer for
20 min. The sections were then incubated with primary anti-
bodies at 4°C overnight. After washing with PBS solution three
times for 5 min, the sections were incubated with horseradish
peroxidase-conjugated anti mouse/rabbit immunoglobulin G
(secondary antibodies) for 30 min at room temperature. The
immune complex was visualized by incubation with
diaminobenzidine (DAB Kit; Maixin Biological, Fuzhou,
China) for 5 min. The sections were then lightly counterstained
with hematoxylin, dehydrated, and mounted. For negative con-
trols, the Tris-buffered saline (TBS) solution was used instead
of the primary antibody.
Results
Preparation of rabbit anti-imp13 antibody. GST-tagged
full-length imp13 protein was expressed and partially purified
Figure 1. Preparation of a rabbit anti-imp13 antibody. (A) SDS–
PAGE of GST-tagged imp13 proteins. Lane 1 whole cell lysates before
IPTG induction. Lane 2 whole cell lysates after IPTG induction. Lane
3 the supernatant of cell lysates after IPTG induction. Lane 4 purified
GST-tagged imp13 using Glutathione Sepharose 4B beads. (B) West-
ern blot analysis for the retained GST antibody in the anti-sera. GST-
tagged imp13 and GST proteins were separated by 10% SDS–PAGE
and proteins were transferred to a nitrocellulose membrane. Lanes 1–4
blots were probed with anti-serum prepared primary antibody
(1:2,000), followed by goat-anti rabbit IgG/HRP secondary antibody.
And retained GST antibody was detected in the anti-serum before
treatment (lanes 1 and 2). No GST antibody was detected in the anti-
sera after treatment with GST beads (lanes 3 and 4). Lanes 5–6 blots
were probed with anti-GST primary antibody (1:1,000) as a control.
Figure 2. Expressions of imp13 in fetal brains at the indicated stages.
A Expressions of IPO13 in the brains at the indicated stages were
analyzed with real-time RT–PCR analyses. B Expressions of imp13
protein in mouse fetal brain at the indicated stages were analyzed with
Western blot analyses. Relative quantification real-time RT–PCR anal-
yses were normalized to Hprt loading controls. Error bars represent the
standard error of the mean (SEM); Western blot analyses were normal-
ized against tubulin loading controls.
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in bacterial cells (Fig. 1A, lanes 2, 3, and 4). Because the
rabbits were immunized against a GST-tagged imp13, their
serum should contain antibodies against imp13 and antibodies
against the GST tag as well (Fig. 1B, lanes 1 and 2). By
incubation of the serum with GST immobilized Glutathione
Sepharose 4B beads, the anti-GST antibodies in the serum
were removed and the treated serum does not recognize the
GST tag but is able to detect imp13 (Fig. 1B, lanes 3 and 4).
Therefore, we generated an anti-imp13 antibody which was
used in the present study.
Expression of imp13 in the brain is temporal-specific during
development. The expression of imp13 has been suggested
to be regulated in multiple fetal tissues (Quan et al. 2008).
Since imp13 transports several transcription factors which
are essential in brain development (Ploski et al. 2004; Lin et
al. 2009), it is of interest to examine the expression of
imp13 in mouse brain development. To this end, we
carried out two parallel experiments. First, we applied
the real-time RT–PCR analysis to quantify its mRNA
levels of IPO13 from fetal brain tissues of mice. Total
RNAs were isolated from the brain at E13.5, E15.5, and
E17.5 embryos as well as at P0 and of adult mice. The
level of IPO13 mRNA was normalized to HPRT internal
control and presented in Fig. 2A. Interestingly, IPO13
expression level in fetal brain tissues was found to be
the highest at E13.5 and then gradually decreased. By
contrast, the expression of IPO13 from adult mouse brain
tissues was shown to be the lowest level among the time
point examined. Meanwhile, Western blot analyses further
confirmed the temporal-specific expression pattern of
imp13 (Fig. 2B).
Figure 3. Cellular localization of imp13 (A–E), imp9 (F–J), and
impβ1 (K–O) in fetal and nascent brain. A–O, Immunohistochemical
staining of sagittal sections (E11.5–E15.5) or coronal section (E17.5
and P0) of the brains at the indicated stages was employed to assess
cellular localization of imp13, imp9, or impβ1. Black arrows indicate
nuclear localizations and white arrows indicate cytosol localizations.
Impβ1 is expressed lowly during brain development (K–O). P–T H&E
staining of sagittal sections (E11.5–E15.5) or coronal section (E17.5
and P0) of whole mouse embryos or brains at the indicated stages. Red
arrows indicate fetal and nascent mouse telencephalon (P, Q) or
cerebral cortex (R–T). A, F, K: E11.5; B, G, L: E13.5; C, H, M:
E15.5; D, I, N: E17.5; E, J, O: P0 (original magnification ×400). The
inset is the high magnification view (original magnification ×1,000).
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In order to localize imp13 in developing brains, we then
employed the immunohistochemical staining (IHC) method.
Distribution of endogenous imp9 and impβ1, two other
members of the importin-β super family, was used as con-
trol. In the tissue of telencephalon, endogenous imp13 was
mainly localized in the cytoplasm of at E11.5 (Fig. 3A).
At E13.5, imp13 is in both the cytoplasm and nucleus
(Fig. 3B). By contrast, at later stages from E15.5 to P0,
imp13 is mainly in the nucleus and only a weak staining
of imp13 can be observed in the cytoplasm (Fig. 3C–E).
Endogenous imp9 resides mainly in the cytoplasm of telen-
cephalon in all stages (Fig. 3F–J). A similar distribution
pattern of imp13 was also observed in cerebellar primordi-
um (Fig. 4A–C), striatum (Fig. 5A, B), and external capsule
(Fig. 5I, J). In the hippocampus, however, imp13 was found
to be in both the cytoplasm and the nucleus from the early to
late stage (Fig. 5Q, R), which was similar to that of imp9
(Fig. 5S, T) and impβ1 (Fig. 5U, V). This may suggest the
existence of different neural progenitor cells in the hippo-
campus area (Hildrestrand et al. 2009). Only a weak staining
of impβ1 could be observed in the mouse developing brain
(Fig. 3K–O; Fig. 4G–I; Fig. 5E–F, M–N, U–V).
Discussion
In this work, an antibody against full-length imp13 was gen-
erated and the expression and subcellular distribution of en-
dogenous imp13 during the development of embryonic mouse
brain were systematically examined. Both the expression and
the subcellular distribution of imp13 in fetal brain are found to
be regulated: at early developmental stages, its expression level
is higher than that at later stages. Imp13 is mainly in the
cytoplasm of telencephalon at early developmental stages,
but it is concentrated in the nucleus of telencephalon when
mice were born. Since imp13 is one of importin-β superfamily
which plays crucial roles in nucleocytoplasmic transport, our
results suggest that its function is probably regulated spatial–
temporally in brain development.
The nucleocytoplasmic transport has been suggested
to be highly regulated at different levels such as cargo,
importin-βs, and NPCs (Major et al. 2011). Even subtle
changes of them may result in significant impact on biolog-
ical processes and dramatic influences on cell signaling.
Imp13-mediated nuclear import of transcription factors in
response to regulatory signaling governs organogenesis
Figure 4. Cellular localization
of imp13 (A–C), imp9 (D–F),
and impβ1 (G–I) in fetal mouse
cerebellar primordium or
cerebellum at differential
stages. Black arrows indicate





Red arrows indicate fetal mouse
cerebellar primordium (J, K) or
cerebellum (L). A, D, G: E11.5;
B, E, H: E13.5; C, F, I: E15.5
(original magnification ×400).
The inset is the high
magnification view (original
magnification ×1,000).
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during embryonic development. We have reported pre-
viously that the imp13 primarily is localized in the
nucleus in fetal lung and that imp13 enters the nucleus
much more rapidly at E18 than at E21 (Tao et al.
2004). Total nuclear recovery of imp13 was significant-
ly different at these two time points. In this study,
different subcellular distribution patterns of imp13 are
found during the development of fetal brain comparing
with impβ1 and imp9, which may indicate its distinct
roles in this process. It is also possible that nuclear
localization of imp13 may reflect selective nuclear re-
tention to reduce its nucleocytoplasmic transport activi-
ties at late brain development.
Regulated synthesis of specific importin proteins has
been shown to mediate cell fate outcomes in embryonic
stem cell systems (Perez-Terzic et al. 2007; Yasuhara et al.
2007; Young et al. 2011). Expression of imp13 shows a
higher level in early developmental brain (Fig. 2A, B),
suggesting that there might be a heavier nucleocytoplasmic
transport of cargoes by imp13 when mouse neurogenesis
starts (Hartfuss et al. 2001; Noctor et al. 2002; Gotz and
Huttner 2005).
Imp13 is one of two members in importin-β superfamily
which can transport cargoes in and out of the nucleus
(Mingot et al. 2001). It is not clear when imp13 only/mainly
imports or exports cargoes. It is possible that imp13 mainly
functions in importing transcription factors such as Pax6
or Arx at early developmental stages but functions mainly
in exporting cargoes such as eIF1A at late developmental
stages in this case. Mechanisms in cells to regulate the
functional transition of imp13 from import to export or
vice versa could be related to unknown factors in brain
development.
In summary, subcellular localization of endogenous
imp13 is shown for the first time to be regulated throughout
fetal brain development, suggesting a potential for neural
cell-specific nucleocytoplasmic transport mechanisms to
govern brain development.
Figure 5. Cellular localization of imp13 (A, B, I, J, Q, R), imp9
(C, D, K, L, S, T), and impβ1 (E, F, M, N, U, V) in fetal mouse
and neonatal (P0) mouse’s striatum, external capsule, and hippo-
campus at differential stages. Black arrows indicate nuclear local-
izations and white arrows indicate cytosol localizations; imp9 and
impβ1 are expressed lowly in the striatum (C, D, E, F) and
external capsule (K, L, M, N). Red arrows indicate fetal mouse
(E17.5) and neonatal (P0) mouse’s striatum (G, H), external
capsule (O, P), and hippocampus (W, X). A, C, E, I, K, M, Q,
S, U: E17.5; B, D, F, J, L, N, P, T, V: P0 (original magnification
×400). The inset is the high magnification view (original magni-
fication ×1,000).
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